- Conditions
- Acute Burns
- Interventions
- Magellan®, Placebo Saline Gel and Usual and Customary Standard of Care
- Device · Other
- Lead sponsor
- Arteriocyte, Inc.
- Industry
- Eligibility
- 18 Years to 86 Years
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2018
- U.S. locations
- 3
- States / cities
- Sacramento, California • Washington D.C., District of Columbia • Salt Lake City, Utah
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–6
of 6
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Sprain of Ankle
- Interventions
- Platelet rich plasma injection, Placebo Comparator: Placebo/Standard of Care
- Procedure
- Lead sponsor
- Albert Einstein Healthcare Network
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 38 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers
- Interventions
- Autologous PRP Gel, Autologous PRP Injections, Autologous PRP Gel plus PRP Injections, Standard Wound Care
- Device · Procedure
- Lead sponsor
- Arteriocyte, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2014
- U.S. locations
- 6
- States / cities
- Bakersfield, California • Idaho Falls, Idaho • Englewood, New Jersey + 3 more
- Conditions
- Critical Limb Ischemia (CLI), Peripheral Vascular Disease (PVD)
- Interventions
- Magellan®
- Device
- Lead sponsor
- Arteriocyte, Inc.
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2016
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Compartment Syndrome
- Interventions
- Magellan®
- Device
- Lead sponsor
- Arteriocyte, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 1
- States / cities
- Oak Lawn, Illinois
- Conditions
- Acute Deep Partial Thickness Thermal Burns
- Interventions
- Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™)
- Device
- Lead sponsor
- Arteriocyte, Inc.
- Industry
- Eligibility
- 18 Years to 86 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 8
- States / cities
- Phoenix, Arizona • Sacramento, California • Washington D.C., District of Columbia + 5 more